Arrowhead Pharmaceuticals Inc (ARWR)

EBITDA Margin

-19.97%

TTM · Period ending:

ARWR logo

ARWR EBITDA Margin

Latest reported-19.97%
ARWR TTM EBITDA Margin (-100.00% → -19.97%)
High-resolution chart · PNG

ARWR ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Arrowhead Pharmaceuticals Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-19.9655%
-21.6183%
33.9348%
19.8713%
-9.1636%
-12.4947%
-23,227.52%
-15,812.8133%
-2,586.8078%
-1,237.8541%
-147.7248%
-72.9732%
-61.2666%
-48.195%
-50.2691%
-67.5942%
-58.2618%
-40.2547%
-124.1566%
-101.7948%
-117.7427%
-124.8554%
-132.5496%
-99.1168%
-22.7658%
4.2156%
30.5107%
38.881%
32.8817%
11.2099%
-55.9136%
-317.4115%
-370.5033%
-180.9514%
-102.3232%
-102.8584%
-185.3033%
-417.8304%
-1,598.2133%
-48,272.8585%
-47,944.7367%
-30,837.1737%
-34,257.6604%
-24,511.8717%
-23,343.6055%
-28,590.7189%
-22,509.1079%
-28,433.2834%
-21,398.2177%
-16,943.1811%
-13,585.9263%
-7,417.2717%
-6,497.8289%
-7,000.8379%
-7,135.0509%
-13,167.8189%
-16,733.7745%
-22,788.1412%
-41,238.3171%
-3,228.9861%
-1,869.8087%
-1,789.8837%
-92.5335%
-66.0546%
-91.2923%
-67.1036%
-381.788%
-492.8151%
-756.4786%
-3,068.3044%
-2,238.181%
-2,620.3927%
-1,765.6579%
-1,623.2843%
-2,451.0434%
-3,048.9992%
-5,067.0861%
-8,513.3246%
-6,440.0257%
-3,768.9555%
-2,055.8021%
-2,035.5675%
-1,384.5701%
-1,281.0905%
-1,328.9498%
-1,266.7443%
-1,264.9968%
-1,372.0156%
-3,455.2527%
-340,316.9082%
-18,586.9686%
-3,369.6718%
-50,617.9197%
-50,567.0353%
-56,866.2505%
-62,097.7935%
-4,204.1422%
-1,577.4983%
-1,735.798%
-1,096.9716%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.